| Natural history and outcome in systemic AA amyloidosis HJ Lachmann, HJB Goodman, JA Gilbertson, JR Gallimore, CA Sabin, ... New England Journal of Medicine 356 (23), 2361-2371, 2007 | 897 | 2007 |
| Use of canakinumab in the cryopyrin-associated periodic syndrome HJ Lachmann, I Kone-Paut, JB Kuemmerle-Deschner, KS Leslie, ... New England Journal of Medicine 360 (23), 2416-2425, 2009 | 833 | 2009 |
| Nonbiopsy diagnosis of cardiac transthyretin amyloidosis JD Gillmore, MS Maurer, RH Falk, G Merlini, T Damy, A Dispenzieri, ... Circulation 133 (24), 2404-2412, 2016 | 752 | 2016 |
| Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis HJ Lachmann, DR Booth, SE Booth, A Bybee, JA Gilbertson, JD Gillmore, ... New England Journal of Medicine 346 (23), 1786-1791, 2002 | 692 | 2002 |
| Spectrum of clinical features in Muckle‐Wells syndrome and response to anakinra PN Hawkins, HJ Lachmann, E Aganna, MF McDermott Arthritis & Rheumatism: Official Journal of the American College of …, 2004 | 634 | 2004 |
| Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis MB Pepys, J Herbert, WL Hutchinson, GA Tennent, HJ Lachmann, ... Nature 417 (6886), 254-259, 2002 | 593 | 2002 |
| Interleukin-1-receptor antagonist in the Muckle-Wells syndrome PN Hawkins, HJ Lachmann, MF McDermott New Engl J Med 348 (25), 2583-2584, 2003 | 497 | 2003 |
| Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy HJ Lachmann, R Gallimore, JD Gillmore, HD Carr‐Smith, AR Bradwell, ... British journal of haematology 122 (1), 78-84, 2003 | 496 | 2003 |
| Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA … E Aganna, F Martinon, PN Hawkins, JB Ross, DC Swan, DR Booth, ... Arthritis & Rheumatism 46 (9), 2445-2452, 2002 | 369 | 2002 |
| Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations HJ Lachmann, B Şengül, TU Yavuzşen, DR Booth, SE Booth, A Bybee, ... Rheumatology 45 (6), 746-750, 2006 | 349 | 2006 |
| Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review N Ter Haar, H Lachmann, S Özen, P Woo, Y Uziel, C Modesto, ... Annals of the rheumatic diseases 72 (5), 678-685, 2013 | 345 | 2013 |
| In vivo regulation of interleukin 1β in patients with cryopyrin-associated periodic syndromes HJ Lachmann, P Lowe, SD Felix, C Rordorf, K Leslie, S Madhoo, ... Journal of Experimental Medicine 206 (5), 1029-1036, 2009 | 332 | 2009 |
| Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis M Fontana, S Pica, P Reant, A Abdel-Gadir, TA Treibel, SM Banypersad, ... Circulation 132 (16), 1570-1579, 2015 | 324 | 2015 |
| Native T1 mapping in transthyretin amyloidosis M Fontana, SM Banypersad, TA Treibel, V Maestrini, DM Sado, SK White, ... JACC: Cardiovascular Imaging 7 (2), 157-165, 2014 | 294 | 2014 |
| Safety and efficacy of risk-adapted cyclophosphamide, thalidomide, and dexamethasone in systemic AL amyloidosis AD Wechalekar, HJB Goodman, HJ Lachmann, M Offer, PN Hawkins, ... Blood 109 (2), 457-464, 2007 | 284 | 2007 |
| Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival CP Venner, T Lane, D Foard, L Rannigan, SDJ Gibbs, JH Pinney, ... Blood, The Journal of the American Society of Hematology 119 (19), 4387-4390, 2012 | 274 | 2012 |
| Eprodisate for the treatment of renal disease in AA amyloidosis LM Dember, PN Hawkins, BPC Hazenberg, PD Gorevic, G Merlini, ... New England Journal of Medicine 356 (23), 2349-2360, 2007 | 274 | 2007 |
| T1 mapping and survival in systemic light-chain amyloidosis SM Banypersad, M Fontana, V Maestrini, DM Sado, G Captur, A Petrie, ... European heart journal 36 (4), 244-251, 2015 | 270 | 2015 |
| T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells G Arbore, EE West, R Spolski, AAB Robertson, A Klos, C Rheinheimer, ... Science 352 (6292), 2016 | 269 | 2016 |
| The pathogenesis and diagnosis of acute kidney injury in multiple myeloma CA Hutchison, V Batuman, J Behrens, F Bridoux, C Sirac, A Dispenzieri, ... Nature Reviews Nephrology 8 (1), 43-51, 2012 | 258 | 2012 |
Philip HawkinsProfessor of MedicineVerified email at ucl.ac.uk
